Decide on other brokers are recommended as different agents according to administration difficulties and/or adverse effect profile.  Zidovudine combined with lamivudine is the choice NRTI spine but is associated with far more hematologic toxicity. Lopinavir/ritonavir is an alternate PI agent with established protection but exhibits increased gastr